<div dir="ltr"><p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span lang="ES" style="font-size:11pt;font-family:Arial,sans-serif;color:black">(</span><span style="font-size:11pt;font-family:Arial,sans-serif;color:black">Apologies for cross-posting)</span><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" align="center" style="text-align:center;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">CFP MultiCardioNER (CLEF/BioASQ 2024):
Clinical Named Entity Recognition adaptation shared task (multilingual &
cardiology)</span></b></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" align="center" style="text-align:center;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><u><span style="font-size:10pt;color:rgb(17,85,204)"><a href="https://temu.bsc.es/multicardioner/" style="color:blue">https://temu.bsc.es/multicardioner/</a></span></u><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" align="center" style="text-align:center;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:11pt;font-family:Arial,sans-serif;color:black"> </span><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" style="text-align:justify;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">The </span><span lang="EN-US" style="font-size:10pt;color:black">MultiCardioNER</span><span style="font-size:10pt;color:black"> track focuses on the</span><span style="font-size:10pt;color:black"> <span lang="EN-US">adaptation of clinical NER systems to specific high impact clinical
application domains (</span></span><span style="font-size:10pt;color:black">cardiovascular
diseases</span><span lang="EN-US" style="font-size:10pt;color:black">,</span><span lang="EN-US" style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">the leading cause of death globally</span><span lang="EN-US" style="font-size:10pt;color:black">) as well as to
multiple languages (English, Spanish and Italian), focusing on two clinical
entity types: diseases and medications.</span><span style="font-size:10pt;color:black"></span></p>
<p class="MsoNormal" style="text-align:justify;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Key
information:</span></b><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><b><span style="font-size:10pt;color:black">Web</span></b><span style="font-size:10pt;color:black">: <a href="https://temu.bsc.es/multicardioner">https://temu.bsc.es/multicardioner</a></span><span style="font-size:10pt;font-family:Arial,sans-serif;color:black"></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><b><span style="font-size:10pt;color:black">Data</span></b><span style="font-size:10pt;color:black">:</span> <span style="font-size:10pt;color:rgb(17,85,204)"><a href="https://zenodo.org/records/10948355">https://zenodo.org/records/10948355</a></span><span style="font-size:10pt;font-family:Arial,sans-serif;color:black"></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><b><span lang="EN-US" style="font-size:10pt;color:black">BioASQ</span></b><b><span style="font-size:10pt;color:black"> web</span></b><span style="font-size:10pt;color:black">: <a href="http://bioasq.org/">http://bioasq.org/</a></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 51.8pt;vertical-align:baseline;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><b><span style="font-size:10pt;color:black">Registration</span></b><b><span lang="EN-US" style="font-size:10pt;color:black">:</span></b><b><span lang="EN-US" style="font-size:10pt;color:black"> </span></b><span style="font-size:10pt;color:black"><a href="https://temu.bsc.es/multicardioner/registration/">https://temu.bsc.es/multicardioner/registration/</a></span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:rgb(17,85,204)"><br>
</span><b><span style="font-size:10pt;color:black">Motivation<br>
</span></b><span style="font-size:10pt;color:black">The
extraction of clinical variables from medical content is key to enable efficient healthcare data analytics. Due to the highly specialized medical language, with
considerable variation depending on the medical </span><span lang="EN-US" style="font-size:10pt;color:black">discipline</span><span style="font-size:10pt;color:black">, more specialized automatic semantic
annotation resources are needed, not only for English but also other languages.
</span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">This is particularly true for clinical
content related to cardiovascular diseases (CVDs), which represent the
leading cause of death globally, responsible for approximately 17.9 million
deaths/year.</span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span lang="EN-US" style="font-size:10pt;color:black">The</span><span lang="EN-US" style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">MultiCardioNER </span><span lang="EN-US" style="font-size:10pt;color:black">task </span><span style="font-size:10pt;color:black">will focus on the automatic recognition
of two key clinical variables or concept types, namely diseases and medications</span><span style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">in cardiology clinical case documents
with the following two aims:</span></p>
<p class="gmail-MsoListParagraphCxSpFirst" style="margin:10pt 0cm 0cm 36pt;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Adaptation
of general clinical concept recognition systems to cardiology case reports to
assess and determine how well such systems can be adapted to high impact
clinical application domains / specialties (cardiology disease NER - CardioDis
subtrack: Spanish).</span></p>
<p class="gmail-MsoListParagraphCxSpLast" style="margin:10pt 0cm 0cm 36pt;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Promote
the comparative assessment and development of clinical entity recognition
systems for multiple languages (i.e., medication mention detection) as well as
adaptation to specific medical specialties (MultiDrug subtrack: English,
Spanish and Italian)</span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">To enable the adaptation of general
medical NER systems for diseases and medications the MultiCardioNER task will
rely on a training collection of 1000 general clinical case reports in Spanish
annotated with diseases (Spanish) and medications (English, Spanish and
Italian).</span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">Moreover, </span><span lang="EN-US" style="font-size:10pt;color:black">t</span><span style="font-size:10pt;color:black">o be able to adapt such general medical
NER approaches to cardiology case reports a development set of 250 cardiology
cases will be released.</span><span style="font-size:10pt;color:black"> </span><span style="font-size:10pt;color:black">The test
set will consist of an additional test collection of 250 cardiology case
reports</span><span lang="EN-US" style="font-size:10pt;color:black">.</span></p>
<p class="MsoNormal" style="margin:10pt 0cm 0cm;text-align:justify;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black">The evaluation of systems for this task
will use flat evaluation, mainly micro-averaged Precision, Recall and F-measure
(MiF).</span></p>
<p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" style="margin:0cm 0cm 12pt;font-size:12pt;font-family:Calibri,sans-serif"><span lang="ES" style="font-family:Arial,sans-serif">S</span><span style="font-size:10pt;color:black">ub-tracks:</span><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Subtask 1 (CardioDis): </span></b><span style="font-size:10pt;color:black">Spanish adaptation of disease
recognition systems to the cardiology domain<b></b></span></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black"> </span></b></p>
<p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><b><span style="font-size:10pt;color:black">Subtask 2 (MultiDrug): </span></b><span style="font-size:10pt;color:black">Multilingual (Spanish, English and
Italian) adaptation of medication recognition systems to the cardiology domain<br><b><br></b></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><b><br></b></span></p><p class="MsoNormal" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><b>Tentative schedule</b></span><span style="font-family:Arial,sans-serif"></span></p>
<p class="gmail-MsoListParagraphCxSpFirst" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">MultiCardioNER
Train+Dev Set Release April 9th,
2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">MultiCardioNER
Annotation Guidelines Release April
17th, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">MultiCardioNER
Gazetteer Release April 17th, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">MultiCardioNER
Test Set Texts Release May 2nd,
2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Participant
Test Predictions Deadline</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">May 15th,
2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Participant
Evaluation Result Release May
19th, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Submission
of Participant Papers Deadline May
31st, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Notification
of Acceptance of Participant Papers June
24th, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpMiddle" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;font-family:Symbol;color:black">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman"">
</span></span><span style="font-size:10pt;color:black">Submission
of Camera-ready Participant Papers Deadline July
8th, 2024</span></p>
<p class="gmail-MsoListParagraphCxSpLast" style="margin:0cm 0cm 0cm 36pt;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Symbol">·<span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal;font-kerning:auto;font-feature-settings:normal;font-stretch:normal;font-size:7pt;line-height:normal;font-family:"Times New Roman""> </span></span><span style="font-size:10pt;color:black">BioASQ @ CLEF2024 September 9th-12th, 2024<br>
<br>
<br>
</span><span style="font-family:Arial,sans-serif"></span></p>
<p style="margin:0cm;background-image:initial;background-position:initial;background-size:initial;background-repeat:initial;background-origin:initial;background-clip:initial;font-size:12pt;font-family:"Times New Roman",serif"><b><span style="font-size:10pt;font-family:Arial,sans-serif">Publications & conference</span></b><span style="font-size:10pt;font-family:Arial,sans-serif"></span></p>
<p style="margin:0cm;text-align:justify;background-image:initial;background-position:initial;background-size:initial;background-repeat:initial;background-origin:initial;background-clip:initial;font-size:12pt;font-family:"Times New Roman",serif"><span style="font-variant-numeric:normal;font-variant-east-asian:normal;font-variant-alternates:normal"><span style="font-size:10pt;font-family:Arial,sans-serif">Following previous BioASQ/CLEF efforts,
participating teams will be invited to contribute a short systems description
paper for the CLEF 202</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">4</span><span style="font-size:10pt;font-family:Arial,sans-serif"> proceedings, and to
give a short presentation of their approach at the BioASQ workshop at the CLEF
202</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">4</span><span style="font-size:10pt;font-family:Arial,sans-serif"> conference (September 09-12, 2024, in Grenoble</span><span lang="EN-US" style="font-size:10pt;font-family:Arial,sans-serif">, </span><span style="font-size:10pt;font-family:Arial,sans-serif">France)</span></span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><br>
<br>
</span><span style="font-family:Arial,sans-serif"></span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt;color:black"><br>
</span><b><span style="font-size:10pt;color:black">The </span></b><b><span lang="EN-GB" style="font-size:10pt;color:black">MultiCardioNER
Organizers & collaborators:</span></b><b><span lang="ES" style="font-size:10pt;color:black"></span></b></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><b><span lang="ES" style="font-size:10pt;color:black"> </span></b></p>
<ul style="margin-top:0cm;margin-bottom:0cm" type="disc">
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Salvador Lima-López, Barcelona Supercomputing
Center (BSC), Spain</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Eulàlia Farré-Maduell, Barcelona
Supercomputing Center (BSC), Spain</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jan Rodríguez-Miret, Barcelona Supercomputing
Center (BSC), Spain</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Martin Krallinger, Barcelona Supercomputing
Center (BSC), Spain</span></li>
</ul>
<ul style="margin-top:0cm;margin-bottom:0cm" type="disc">
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anastasios Nentidis, National Center for
Scientific Research Demokritos, Greece</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anastasia Krithara, National Center for
Scientific Research Demokritos, Greece</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Georgios Katsimpras, National Center for
Scientific Research Demokritos, Greece</span></li>
</ul>
<ul style="margin-top:0cm;margin-bottom:0cm" type="disc">
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Livia Lilli, Fondazione Policlinico
Universitario Agostino Gemelli IRCCS, Italy</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jacopo Lenkowicz, Fondazione Policlinico
Universitario Agostino Gemelli IRCCS, Italy</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Jonathan Kossoff, University College London
Hospitals NHS Foundation Trust, UK</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Giovanna Ceroni, University College London, UK</span></li>
<li class="MsoNormal" style="color:black;margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-size:10pt">Anoop Shah, University College London
Hospitals NHS Foundation Trust, UK</span></li>
</ul>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"><br><br>
</span></p>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"><span style="font-family:Arial,sans-serif"> </span></p>
<div>=======================================<br>Martin Krallinger, Dr.<br><span style="font-family:arial,helvetica,sans-serif">Head of NLP for Biomedical Information Analysis Unit<br></span><span style="font-family:arial,helvetica,sans-serif">Barcelona Supercomputing Center (BSC-CNS)</span></div><div><font face="arial, helvetica, sans-serif"><a href="https://www.linkedin.com/in/martin-krallinger-85495920/" target="_blank">https://www.linkedin.com/in/martin-krallinger-85495920/</a><br></font> =======================================</div>
<p class="MsoNormal" style="margin:0cm;font-size:12pt;font-family:Calibri,sans-serif"> </p></div>